Commerce to Announce Third Quarter 2025 Financial Results on November 6, 2025 Conference Call…
Cycurion, Inc. Announces Nasdaq Delisting Determination Letter MCLEAN, Va., Oct. 20, 2025 (GLOBE NEWSWIRE)…
CLEAR and Wellstar Health System Modernize the Patient Experience Using CLEAR1’s Digital Check-In Wellstar…
Broadridge Schedules Webcast and Conference Call to Review First Quarter Fiscal Year 2026 Results…
CaseBioscience® Launches CaseBio™ Culture and CaseBio™ Handling Media at ASRM 2025 After FDA 510(k)…
Opera announces deep research agent for Opera Neon As the browser get its fourth…
Dover Food Retail Announces Expansion of Manufacturing Campus in Virginia DOWNERS GROVE, Ill., Oct.…
La FDA autorise le système d’implant de pied et de cheville SINAPTIC® de SINTX…
SINTX Technologies 獲 FDA 批准 SINAPTIC® 足踝植入系統 獲 FDA 批准並在美國製造的植入系統推動 SINTX 進軍價值數十億美元的美國市場 獲 FDA…
SINTX Technologies 的 SINAPTIC® 足踝植入系统获得 FDA 上市许可 获 FDA 批准且在美国本土制造的植入系统,为 SINTX 进军规模达数十亿美元的美国市场奠定了基础 获 FDA…
Sign in to your account